ID

37649

Descrizione

Study ID: 104864/612 Clinical Study ID: 104864/612 Study Title: A Prospective, Open Label Phase II Study to Evaluate the Efficacy and Safety of Topotecan (HycamtinTM) in Combination with Carboplatin as First-line Chemotherapy in Patients with Ovarian Cancer Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: N/A Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 2 Study Recruitment Status: Completed Generic Name: Topotecan Trade Name: HycamtinTM Study Indication: Ovarian Cancer

Keywords

versioni (1)
  1. 13/08/19 13/08/19 -
Titolare del copyright

GlaxoSmithKline

Caricato su

13 agosto 2019

DOI

Per favore, per richiedere un accesso.

Licenza

Creative Commons BY-NC 3.0
Commenti del modello :

Puoi commentare il modello dati qui. Tramite i fumetti nei gruppi di articoli e articoli è possibile aggiungere commenti a quelli in modo specifico.

Torna ai commenti del modello
Commenti del gruppo di articoli per :

Commenti dell'articolo per :

  • i più nuovi
  • i più vecchi
  • Popolare
  • i più nuovi
    • i più nuovi
    • i più vecchi
    • Popolare

Non ci sono commenti

Per scaricare i modelli di dati devi essere registrato. Per favore accesso o registrati GRATIS.

Topotecan (HycamtinTM) with Carboplatin as First-Line Chemotherapy in Patients with Ovarian Cancer; 104864/612

Inglese

Study End

1 moduli  
  1. StudyEvent: ODM
    1. Study End
Administrative Data
Descrizione

Administrative Data

Alias
UMLS CUI-1
C1320722
Patient Number
Descrizione

Patient number

Tipo di dati

integer

Alias
UMLS CUI [1]
C1830427
Study End
Descrizione

Study End

Alias
UMLS CUI-1
C0008972
UMLS CUI-2
C0444930
Did the patient prematurely terminate the study or was she prematurely withdrawn?
Descrizione

Clinical Trials, Withdraw

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0008976
UMLS CUI [1,2]
C2349954
If "yes", please document the date
Descrizione

Clinical Trials, Withdraw, Date in time

Tipo di dati

date

Alias
UMLS CUI [1,1]
C0008976
UMLS CUI [1,2]
C2349954
UMLS CUI [1,3]
C0011008
If "yes", please provide the primary reason for withdrawal
Descrizione

Clinical Trials, Withdraw, Reason and justification

Tipo di dati

text

Alias
UMLS CUI [1,1]
C0008976
UMLS CUI [1,2]
C2349954
UMLS CUI [1,3]
C0566251
Please specify
Descrizione

Clinical Trials, Withdraw, Reason and justification

Tipo di dati

text

Alias
UMLS CUI [1,1]
C0008976
UMLS CUI [1,2]
C2349954
UMLS CUI [1,3]
C0566251
Confirmation of the investigator
Descrizione

Confirmation of the investigator

Alias
UMLS CUI-1
C2346576
UMLS CUI-2
C0750484
Signature of the responsible investigator I hereby declare that the data documented in his case report form are an exact and correct repetition of the patient's findings, that the trial was conducted according to protocol, and that the patient's consent for the study participation has been obtained.
Descrizione

Investigator Signature

Tipo di dati

text

Alias
UMLS CUI [1]
C2346576
Date
Descrizione

Investigator Signature, Date in time

Tipo di dati

date

Alias
UMLS CUI [1,1]
C2346576
UMLS CUI [1,2]
C0011008
Name in printed letters or practice stamp
Descrizione

Investigator Name

Tipo di dati

text

Alias
UMLS CUI [1]
C2826892
Ritorna all'inizio della pagina

Similar models

Study End

1 moduli
  1. StudyEvent: ODM
    1. Study End
Name
genere
Description | Question | Decode (Coded Value)
Tipo di dati
Alias
Item Group
Administrative Data
C1320722 (UMLS CUI-1)
Patient number
Item
Patient Number
integer
C1830427 (UMLS CUI [1])
Item Group
Study End
C0008972 (UMLS CUI-1)
C0444930 (UMLS CUI-2)
Clinical Trials, Withdraw
Item
Did the patient prematurely terminate the study or was she prematurely withdrawn?
boolean
C0008976 (UMLS CUI [1,1])
C2349954 (UMLS CUI [1,2])
Clinical Trials, Withdraw, Date in time
Item
If "yes", please document the date
date
C0008976 (UMLS CUI [1,1])
C2349954 (UMLS CUI [1,2])
C0011008 (UMLS CUI [1,3])
Item
If "yes", please provide the primary reason for withdrawal
text
C0008976 (UMLS CUI [1,1])
C2349954 (UMLS CUI [1,2])
C0566251 (UMLS CUI [1,3])
Clinical Trials, Withdraw, Reason and justification
Code List
If "yes", please provide the primary reason for withdrawal
CL Item
Adverse event (1)
CL Item
Insufficient therapeutic effect (2)
CL Item
Protocol violation (incl. non-compliance) (3)
CL Item
Patient is lost to follow-up (4)
CL Item
Other, please specify (5)
Clinical Trials, Withdraw, Reason and justification
Item
Please specify
text
C0008976 (UMLS CUI [1,1])
C2349954 (UMLS CUI [1,2])
C0566251 (UMLS CUI [1,3])
Item Group
Confirmation of the investigator
C2346576 (UMLS CUI-1)
C0750484 (UMLS CUI-2)
Investigator Signature
Item
Signature of the responsible investigator I hereby declare that the data documented in his case report form are an exact and correct repetition of the patient's findings, that the trial was conducted according to protocol, and that the patient's consent for the study participation has been obtained.
text
C2346576 (UMLS CUI [1])
Investigator Signature, Date in time
Item
Date
date
C2346576 (UMLS CUI [1,1])
C0011008 (UMLS CUI [1,2])
Investigator Name
Item
Name in printed letters or practice stamp
text
C2826892 (UMLS CUI [1])
Ritorna all'inizio della pagina 

Contatto

Si prega di utilizzare questo modulo per feedback, domande e suggerimenti per miglioramenti.

I campi contrassegnati da * sono obbligatori.

Aiuto

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial